Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John W. Smither currently holds 31,566 shares of KYTHERA BIOPHARMACEUTICALS INC (KYTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John W. Smither has been a net seller of KYTH stock. They have purchased $0 and sold $8.7M worth of shares.
John W. Smither's most recent insider trade was on Jun 16, 2026, when they sold 31,566 shares at $0.00 per share.
John W. Smither serves as Executive at KYTHERA BIOPHARMACEUTICALS INC (KYTH). They have executed 119 insider transactions totaling $8.7M over their tenure at the company.
John W. Smither holds the position of Executive at KYTHERA BIOPHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
John W. Smither has shown a selling trading pattern, with $0 in total purchases and $8.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John W. Smither was on Sep 24, 2015, when they sold $1.0M worth of KYTH shares. This transaction involved 13,763 shares at $74.90 per share.
John W. Smither currently owns 31,566 shares of KYTHERA BIOPHARMACEUTICALS INC (KYTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John W. Smither's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John W. Smither has 119 Form 4 filings on record as an insider at KYTHERA BIOPHARMACEUTICALS INC.
Set alerts for John W. Smither and 40,000+ other insiders.